Al-Dawaa Medical Services Company (TADAWUL:4163)

Market Cap	4.29B
Revenue (ttm)	6.75B
Net Income (ttm)	364.62M
Shares Out	85.00M
EPS (ttm)	4.29
PE Ratio	11.77
Forward PE	11.63
Dividend	1.89 (3.73%)
Ex-Dividend Date	Nov 10, 2025

Volume	25,006
Average Volume	167,590
Open	50.65
Previous Close	50.50
Day's Range	50.40 - 50.95
52-Week Range	48.70 - 87.30
Beta	0.07
RSI	41.14
Earnings Date	Mar 16, 2026

About TADAWUL:4163

Al-Dawaa Medical Services Company, together with its subsidiaries, primarily operates as a pharmaceutical retail company in the Kingdom of Saudi Arabia and Kingdom of Bahrain. The company offers medicines, perfumes, cosmetics, beauty tools, and other pharmaceutical products; and transportation and logistics services. It also involved in pharmacy activities, pharmaceutical warehousing activities, retailing of medical and other equipment, land transport of goods, managing and renting self-storage stores, and provision of marketing services on beh...

• Industry: Medical - Pharmaceuticals
• Sector: Healthcare
• Founded: 1993
• Employees: 5,952
• Stock Exchange: Saudi Stock Exchange
• Ticker Symbol: 4163

Financial Performance

In 2024, TADAWUL:4163's revenue was 6.45 billion, an increase of 12.36% compared to the previous year's 5.74 billion. Earnings were 370.11 million, an increase of 12.42%.